Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · IEX Real-Time Price · USD
5.52
-0.17 (-2.99%)
Apr 12, 2024, 4:00 PM EDT - Market closed

Amneal Pharmaceuticals Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for AMRX stock have an average target of 7.31, with a low estimate of 6.25 and a high estimate of 8.00. The average target predicts an increase of 32.43% from the current stock price of 5.52.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $6.25 $7.31 $8.00 $8.00
Change +13.22% +32.43% +44.93% +44.93%

Analyst Ratings

The average analyst rating for AMRX stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '23Dec '23Jan '24Feb '24Mar '24Apr '24
Strong Buy 222222
Buy 222222
Hold 111100
Sell 000000
Strong Sell 000000
Total 555544

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Piper Sandler
Piper Sandler
Buy
Maintains
$6$8
Buy Maintains $6$8 +44.93% Mar 21, 2024
Goldman Sachs
Goldman Sachs
Strong Buy
Maintains
$5.5$6.25
Strong Buy Maintains $5.5$6.25 +13.22% Mar 4, 2024
Barclays
Barclays
Buy
Maintains
$6$8
Buy Maintains $6$8 +44.93% Jan 29, 2024
Truist Securities
Truist Securities
Strong Buy
Maintains
$6$7
Strong Buy Maintains $6$7 +26.81% Nov 8, 2023
Truist Securities
Truist Securities
Strong Buy
Reiterates
$6
Strong Buy Reiterates $6 +8.70% Sep 6, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
2.64B
from 2.39B
Increased by 10.21%
Revenue Next Year
2.61B
from 2.64B
Decreased by -1.02%
EPS This Year
0.59
from -0.48
EPS Next Year
0.59
from 0.59
Decreased by -0.34%
Year 2019202020212022202320242024202520252026
Revenue
1.63B1.99B2.09B2.21B2.39B2.64B2.61B2.73B2.71B2.82B
Revenue Growth
-2.20%22.51%5.08%5.67%8.20%10.21%-1.02%4.67%-0.95%4.03%
EPS
-2.740.610.07-0.86-0.480.590.590.680.660.69
EPS Growth
---88.52%----0.34%14.66%-3.01%4.91%
No. Analysts -----77675
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 2.8B 3.0B 3.0B
Avg 2.6B 2.7B 2.8B
Low 2.5B 2.5B 2.5B

Revenue Growth

Revenue Growth 202420252026
High
16.0%
13.1%
11.9%
Avg
9.1%
3.7%
4.0%
Low
2.5%
-4.8%
-6.5%

EPS Forecast

EPS 202420252026
High 0.66 0.72 0.78
Avg 0.59 0.66 0.69
Low 0.53 0.58 0.63

EPS Growth

EPS Growth 202420252026
High -
22.5%
18.1%
Avg -
11.2%
4.9%
Low -
-2.3%
-4.7%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.